Metformin as an Anticancer Agent

被引：208
作者：
Vancura, Ales [1 ]
Bu, Pengli [1 ]
Bhagwat, Madhura [1 ]
Zeng, Joey [1 ]
Vancurova, Ivana [1 ]
机构：
[1] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 2018年 / 39卷 / 10期
关键词：
ACTIVATED PROTEIN-KINASE; AMINO-ACID LEVELS; BREAST-CANCER; RAG GTPASES; PROSTATE-CANCER; OPPORTUNITY NEOADJUVANT; HEPATIC GLUCONEOGENESIS; CELL-PROLIFERATION; GLUCOSE-PRODUCTION; CARBON METABOLISM;
D O I：
10.1016/j.tips.2018.07.006
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Metformin has been a frontline therapy for type 2 diabetes (T2D) for many years. Its effectiveness in T2D treatment is mostly attributed to its suppression of hepatic gluconeogenesis; however, the mechanistic aspects of metformin action remain elusive. In addition to its glucose-lowering effect, metformin possesses other pleiotropic health-promoting effects that include reduced cancer risk and tumorigenesis. Metformin inhibits the electron transport chain (ETC) and ATP synthesis; however, recent data reveal that metformin regulates AMP-activated protein kinase (AMPK) and the mechanistic target of rapamycin complex 1 (mTORC1) by multiple, mutually nonexclusive mechanisms that do not necessarily depend on the inhibition of ETC and the cellular ATP level. In this review, we discuss recent advances in elucidating the molecular mechanisms that are relevant for metformin use in cancer treatment.
引用
收藏
页码：867 / 878
页数：12
相关论文
共 103 条
[91]   Understanding the Intersections between Metabolism and Cancer Biology [J].
Vander Heiden, Matthew G. ;
DeBerardinis, Ralph J. .
CELL, 2017, 168 (04) :657-669
[92]   RAPAMYCIN (AY-22,989), A NEW ANTIFUNGAL ANTIBIOTIC .1. TAXONOMY OF PRODUCING STREPTOMYCETE AND ISOLATION OF ACTIVE PRINCIPLE [J].
VEZINA, C ;
KUDELSKI, A ;
SEHGAL, SN .
JOURNAL OF ANTIBIOTICS, 1975, 28 (10) :721-726
[93]   Cellular and molecular mechanisms of metformin: an overview [J].
Viollet, Benoit ;
Guigas, Bruno ;
Sanz Garcia, Nieves ;
Leclerc, Jocelyne ;
Foretz, Marc ;
Andreelli, Fabrizio .
CLINICAL SCIENCE, 2012, 122 (5-6) :253-270
[94]   ACCUMULATION OF METFORMIN BY TISSUES OF THE NORMAL AND DIABETIC MOUSE [J].
WILCOCK, C ;
BAILEY, CJ .
XENOBIOTICA, 1994, 24 (01) :49-57
[95]   Glutamine addiction: a new therapeutic target in cancer [J].
Wise, David R. ;
Thompson, Craig B. .
TRENDS IN BIOCHEMICAL SCIENCES, 2010, 35 (08) :427-433
[96]   An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer [J].
Wu, Lianfeng ;
Zhou, Ben ;
Oshiro-Rapley, Noriko ;
Li, Man ;
Paulo, Joao A. ;
Webster, Christopher M. ;
Mou, Fan ;
Kacergis, Michael C. ;
Talkowski, Michael E. ;
Carr, Christopher E. ;
Gygi, Steven P. ;
Zheng, Bin ;
Soukas, Alexander A. .
CELL, 2016, 167 (07) :1705-+
[97]   New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK [J].
Zadra, Giorgia ;
Priolo, Carmen ;
Patnaik, Akash ;
Loda, Massimo .
CLINICAL CANCER RESEARCH, 2010, 16 (13) :3322-3328
[98]   Metformin Activates AMPK through the Lysosomal Pathway [J].
Zhang, Chen-Song ;
Li, Mengqi ;
Ma, Teng ;
Zong, Yue ;
Cui, Jiwen ;
Feng, Jin-Wei ;
Wu, Yu-Qing ;
Lin, Shu-Yong ;
Lin, Sheng-Cai .
CELL METABOLISM, 2016, 24 (04) :521-522
[99]   The Lysosomal v-ATPase-Ragulator Complex Is a Common Activator for AMPK and mTORC1, Acting as a Switch between Catabolism and Anabolism [J].
Zhang, Chen-Song ;
Jiang, Bin ;
Li, Mengqi ;
Zhu, Mingjiang ;
Peng, Yongying ;
Zhang, Ya-Lin ;
Wu, Yu-Qing ;
Li, Terytty Yang ;
Liang, Yu ;
Lu, Zailian ;
Lian, Guili ;
Liu, Qing ;
Guo, Huiling ;
Yin, Zhenyu ;
Ye, Zhiyun ;
Han, Jiahuai ;
Wu, Jia-Wei ;
Yin, Huiyong ;
Lin, Shu-Yong ;
Lin, Sheng-Cai .
CELL METABOLISM, 2014, 20 (03) :526-540
[100]   AMP as a Low-Energy Charge Signal Autonomously Initiates Assembly of AXIN-AMPK-LKB1 Complex for AMPK Activation [J].
Zhang, Ya-Lin ;
Guo, Huiling ;
Zhang, Chen-Song ;
Lin, Shu-Yong ;
Yin, Zhenyu ;
Peng, Yongying ;
Luo, Hui ;
Shi, Yuzhe ;
Lian, Guili ;
Zhang, Cixiong ;
Li, Mengqi ;
Ye, Zhiyun ;
Ye, Jing ;
Han, Jiahuai ;
Li, Peng ;
Wu, Jia-Wei ;
Lin, Sheng-Cai .
CELL METABOLISM, 2013, 18 (04) :546-555
234567891011